Viruses Most Commonly Associated with Cardiomyopathy
Enteroviruses (particularly Coxsackievirus B) and adenoviruses are the most commonly associated viruses with cardiomyopathy, though in recent years parvovirus B19 has emerged as a predominant pathogen in Western countries. 1
Viral Etiology of Cardiomyopathy
Common Viral Pathogens
- Historical predominance: Coxsackievirus B and other enteroviruses were the most common causes in the 1980s-1990s 1
- Current predominance:
Regional Variations
- In North America and Western Europe: viral infections are the most commonly identified causes 1
- In specific world regions: Chagas disease, post-streptococcal rheumatic heart disease, and HIV are important causes 1
- In Asia: Diphtheria, typhoid fever, rubella, and even scorpion bite have been reported 1
Viral Detection in Cardiomyopathy
Multiple studies have identified various cardiotropic viruses in patients with myocarditis or dilated cardiomyopathy:
- Enteroviruses (especially Coxsackievirus B)
- Adenoviruses
- Parvovirus B19
- Human herpes virus 6
- Cytomegalovirus
- Epstein-Barr virus
- Influenza and respiratory syncytial virus
- Hepatitis C
- HIV 1, 2
Pathophysiology of Viral Cardiomyopathy
Mechanisms of Myocardial Damage
- Direct viral cytotoxicity: Viruses directly damage myocytes during replication 3
- Immune-mediated damage: Host immune response causes inflammation and myocardial injury 3
- Autoimmune response: Molecular mimicry between viral and cardiac antigens leads to ongoing damage 3
Disease Progression
- Acute phase: Direct viral invasion and replication
- Subacute phase: Immune-mediated inflammation
- Chronic phase: Potential progression to dilated cardiomyopathy with or without persistent viral genome 2
Diagnosis of Viral Cardiomyopathy
Diagnostic Approach
- Endomyocardial biopsy (EMB) remains the gold standard for diagnosis of viral myocarditis and cardiomyopathy 1, 4
- PCR techniques on biopsy specimens can identify specific viral genomes 2
- Cardiac MRI is the most sensitive non-invasive test, showing edema and late gadolinium enhancement 4
When to Consider EMB
EMB is reasonable in:
- Unexplained cardiomyopathy in children 1
- New-onset heart failure of 2 weeks' to 3 months' duration with dilated left ventricle 1
- Suspected cardiac tumor or unexplained arrhythmias 1
Clinical Implications and Management
Prognostic Factors
- In children, viral etiology affects prognosis:
Treatment Approaches
- Standard guideline-directed heart failure therapy for reduced ejection fraction 4
- Potential antiviral strategies (still investigational):
Special Considerations
Pediatric Population
- Viral myocarditis is a frequent cause of new-onset DCM in children 1
- Most common causes: enteroviruses, adenoviruses, and parvovirus B19 1
- Children with viral cardiomyopathy may have better survival than those with idiopathic DCM 1
Coinfection
Coinfection with ≥2 viruses occurs in a substantial minority of cases, potentially complicating diagnosis and treatment 1
Emerging Pathogens
SARS-CoV-2 (COVID-19) has emerged as a cause of myocarditis-like cardiac injury, with a hyperinflammatory response that can lead to myocardial damage 1
Pitfalls and Caveats
- Sampling error is common in EMB due to the focal nature of viral myocarditis 6
- Viral genome detection by PCR is highly sensitive but may not always correlate with active disease
- The absence of viral genome on EMB does not exclude viral etiology due to potential sampling error 1
- Viral prevalence has changed over time, so older literature may not reflect current epidemiology 1